Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, investigator says.

When an impressive opening act at the professional level and strong performances at the U23 camp string together, a first ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

Steel and mining company ArcelorMittal (OTCPK:AMSYF) announced on Friday the sale of its operations in Bosnia and Herzegovina ...

An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with ...

Pope Leo XIV has said there should be no tolerance in the Catholic Church for any type of abuse. Leo made his first public ...

Shahs of Sunset alum Lilly Ghalichi has just filed for divorce again from husband Dara Mir making this the 4th divorce filing ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, ...